About Us
- Home
- About Us
Who we are
LIQOMICS is an academic spin-off from Cologne, Germany, focused on advancing liquid biopsy technology for tumor diagnostics. We aim to make our liquid biopsy tests for genotyping and disease monitoring accessible to cancer patients worldwide. Our Vista family of products are ctDNA sequencing tests developed for exploratory genotyping in cancer patients and for detecting minimal residual disease (MRD) in follow-up samples. The tests cover the entire process from cell-free DNA (cfDNA) extraction and quality control to sequencing, target enrichment, and analysis with our in-house pipeline. We offer our tests as in-house IVDs for diagnostic use and as research tools for academic and industry collaborators.
Highly sensitive minimal residual disease (MRD) detection
The Vista family tests are crucial tools for the early detection of low level MRD in cancer patients. With our proprietary workflow and bioinformatics we detect cancer with higher sensitivity than others. This can enable an earlier intervention in case of a relapse and hence an improved disease outcome for the patients.
Some key statistics of our assay
Sensitivity for Genotyping (SNPs / InDels) > 93%
Specificity for Genotyping (SNPs / InDels) > 99.999%
Sensitivity for MRD detection at MRD level > 10-5 > 88%
Specificity for MRD detection at MRD level > 10-5 > 99%
Limit of Detection for MRD ~ 5 x 10-6
Learn more about our assay
Our assay uses tumor mutations that we identify and track in blood to inform on the genetic drivers of a tumor and to quantify minimal residual disease (MRD)
Awards
Certifications & Standards
Certification Process Ongoing
Our Team
How We Work
Partner with us
We are always on the lookout for collaborators.
Academic research, start-up or pharmaceutical industry. If you are excited about blood-based cancer genomics or highly sensitive minimal residual disease assessment across cancers we should start a conversation.
If you are treating cancer patients and would like to use our test for your patients, we are happy to explain to you how to set everything up in a short meeting.
Get in contact with us and let us explore how we can team up.
